Prospective randomised study to evaluate effectiveness of distal embolic protection compared to abciximab administration in reduction of microembolic complications of primary coronary angioplasty.
暂无分享,去创建一个
[1] A. Investigators. Three-year duration of benefit from abciximab in patients receiving stents for acute myocardial infarction in the randomized double-blind ADMIRAL study. , 2005, European heart journal.
[2] F. Neumann,et al. Randomized Evaluation of the Effects of Filter-Based Distal Protection on Myocardial Perfusion and Infarct Size After Primary Percutaneous Catheter Intervention in Myocardial Infarction With and Without ST-Segment Elevation , 2005, Circulation.
[3] M. Hori,et al. Distal Protection Improved Reperfusion and Reduced Left Ventricular Dysfunction in Patients With Acute Myocardial Infarction Who Had Angioscopically Defined Ruptured Plaque , 2005, Circulation.
[4] C. Di Mario,et al. X-sizer for thrombectomy in acute myocardial infarction improves ST-segment resolution: results of the X-sizer in AMI for negligible embolization and optimal ST resolution (X AMINE ST) trial. , 2005, Journal of the American College of Cardiology.
[5] H. Kao,et al. Initial thrombosuction with subsequent angioplasty in primary coronary intervention--comparison with conventional strategy. , 2005, International journal of cardiology.
[6] R. Gibbons,et al. Distal Microcirculatory Protection During Percutaneous Coronary Intervention in Acute ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Trial , 2005 .
[7] S. Oshima,et al. Effectiveness of distal protection with the GuardWire Plus during primary angioplasty for acute myocardial infarction. , 2005, Journal of cardiology.
[8] H. Yip,et al. Six‐month angiographic results of primary angioplasty with adjunctive PercuSurge GuardWire device support: Evaluation of the restenotic rate of the target lesion and the fate of the distal balloon occlusion site , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[9] G. Schuler,et al. Effectiveness and safety of the Proxis system in demonstrating retrograde coronary blood flow during proximal occlusion and in capturing embolic material. , 2004, The American journal of cardiology.
[10] Hiroshi Sato,et al. Comparison of temporary occlusion and aspiration system versus the conventional method during coronary stenting for acute myocardial infarction. , 2004, The American journal of cardiology.
[11] A. Angelini,et al. Distal Protection With a Filter Device During Coronary Stenting in Patients With Stable and Unstable Angina , 2004, Circulation.
[12] M. Kawakami,et al. Effects of a distal protection device during primary stenting in patients with acute anterior myocardial infarction. , 2004, Circulation journal : official journal of the Japanese Circulation Society.
[13] Albert Schömig,et al. Coronary and myocardial angiography: angiographic assessment of both epicardial and myocardial perfusion. , 2004, Circulation.
[14] G. Parodi,et al. Impact of Microvascular Dysfunction on Left Ventricular Remodeling and Long-Term Clinical Outcome After Primary Coronary Angioplasty for Acute Myocardial Infarction , 2004, Circulation.
[15] J. J. Griffin,et al. Benefits and Risks of Abciximab Use in Primary Angioplasty for Acute Myocardial Infarction: The Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial , 2003, Circulation.
[16] G. Fontanini,et al. Mechanical Prevention of Distal Embolization During Primary Angioplasty: Safety, Feasibility, and Impact on Myocardial Reperfusion , 2003, Circulation.
[17] Felix Zijlstra,et al. Angiographic Assessment of Reperfusion in Acute Myocardial Infarction by Myocardial Blush Grade , 2003, Circulation.
[18] J. Boura,et al. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials , 2003, The Lancet.
[19] R. Califf,et al. Effect of abciximab on angiographic complications during percutaneous coronary stenting in the Evaluation of Platelet IIb/IIIa Inhibition in Stenting Trial (EPISTENT). , 2002, The American journal of cardiology.
[20] J. Ottervanger,et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction. , 2002, European heart journal.
[21] M. Leon,et al. Randomized Trial of a Distal Embolic Protection Device During Percutaneous Intervention of Saphenous Vein Aorto-Coronary Bypass Grafts , 2002, Circulation.
[22] R. Kloner,et al. No-reflow phenomenon. , 2002, Circulation.
[23] M. Morice,et al. Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction. , 2001, The New England journal of medicine.
[24] G. Musumeci,et al. Effects of abciximab on microvascular integrity and left ventricular functional recovery in patients with acute infarction treated by primary coronary angioplasty. , 2003, European heart journal.
[25] E. Falk,et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.